Edgewell Personal Care reported QQ1 2025 results that reflect a bifurcated performance landscape: continued strength in international markets and select right-to-win categories, coupled with softness in certain US segments (notably wet shave and fem care). Revenue declined 2.15% year over year to $478.4 million, and net income swung to a net loss of $2.1 million ($-0.04 per share GAAP; $0.07 adjusted EPS). Management emphasized resilience in international growth (2% organic) and ongoing productivity initiatives that delivered 340 basis points of cost savings, supporting a roughly 80 basis points gross margin expansion in constant currency despite FX headwinds. The quarter also showcased meaningful progress in the company’s transformation initiatives, including product innovation and leadership changes in North America, aimed at accelerating growth across the right-to-win portfolio while stabilizing the right-to-play slate in the US.
Looking ahead, EPC reaffirmed its 2025 outlook on an organic basis (1% to 3% net sales growth), while updating the full-year guidance to reflect sharper currency headwinds. The company now expects approximately 70% of adjusted net earnings to be realized in the second half of fiscal 2025, with adjusted EPS targeted at the lower end of the $3.15–$3.35 range and adjusted EBITDA at the lower end of $356–$368 million. FX is expected to be a headwind of roughly 35 bps on gross margin and about $0.36 per share of currency impact in the year, underscoring the sensitivity to macro conditions. Edgewell’s strategic emphasis remains on maintaining brand investments, expanding international share, and accelerating new product introductions (e.g., Shik First Tokyo in Japan and Bulldog in Europe) to drive durable growth. Investors should monitor FX trajectories, inorganic opportunities, and the pace of North American normalization as the year unfolds.